INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

NYSE:INVX • US4576511079

26.35 USD
-0.29 (-1.09%)
At close: Feb 27, 2026
26.3 USD
-0.05 (-0.19%)
After Hours: 2/27/2026, 8:11:30 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

Taking everything into account, INVX scores 7 out of 10 in our fundamental rating. INVX was compared to 61 industry peers in the Energy Equipment & Services industry. INVX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INVX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make INVX a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year INVX was profitable.
  • In the past year INVX had a positive cash flow from operations.
  • In multiple years INVX reported negative net income over the last 5 years.
  • In multiple years INVX reported negative operating cash flow during the last 5 years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of INVX (8.06%) is better than 86.89% of its industry peers.
  • INVX has a Return On Equity of 9.73%. This is in the better half of the industry: INVX outperforms 70.49% of its industry peers.
  • INVX has a better Return On Invested Capital (8.61%) than 75.41% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for INVX is significantly below the industry average of 13.00%.
  • The 3 year average ROIC (5.11%) for INVX is below the current ROIC(8.61%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.06%
ROE 9.73%
ROIC 8.61%
ROA(3y)6.11%
ROA(5y)1.09%
ROE(3y)7.53%
ROE(5y)1.62%
ROIC(3y)5.11%
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • The Profit Margin of INVX (10.58%) is better than 86.89% of its industry peers.
  • INVX's Operating Margin of 12.21% is fine compared to the rest of the industry. INVX outperforms 65.57% of its industry peers.
  • INVX has a better Gross Margin (32.35%) than 70.49% of its industry peers.
  • In the last couple of years the Gross Margin of INVX has grown nicely.
Industry RankSector Rank
OM 12.21%
PM (TTM) 10.58%
GM 32.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.34%
GM growth 5Y3.49%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • INVX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, INVX has less shares outstanding
  • Compared to 5 years ago, INVX has more shares outstanding
  • The debt/assets ratio for INVX has been reduced compared to a year ago.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • INVX has an Altman-Z score of 7.03. This indicates that INVX is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 7.03, INVX belongs to the top of the industry, outperforming 98.36% of the companies in the same industry.
  • INVX has a debt to FCF ratio of 0.19. This is a very positive value and a sign of high solvency as it would only need 0.19 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.19, INVX belongs to the top of the industry, outperforming 93.44% of the companies in the same industry.
  • INVX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of INVX (0.02) is better than 88.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.19
Altman-Z 7.03
ROIC/WACC1
WACC8.61%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 4.78 indicates that INVX has no problem at all paying its short term obligations.
  • The Current ratio of INVX (4.78) is better than 95.08% of its industry peers.
  • A Quick Ratio of 2.93 indicates that INVX has no problem at all paying its short term obligations.
  • INVX's Quick ratio of 2.93 is amongst the best of the industry. INVX outperforms 93.44% of its industry peers.
Industry RankSector Rank
Current Ratio 4.78
Quick Ratio 2.93
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • INVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 335.29%, which is quite impressive.
  • INVX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 67.88% yearly.
  • Looking at the last year, INVX shows a very strong growth in Revenue. The Revenue has grown by 26.86%.
  • INVX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.80% yearly.
EPS 1Y (TTM)335.29%
EPS 3YN/A
EPS 5Y67.88%
EPS Q2Q%-42.86%
Revenue 1Y (TTM)26.86%
Revenue growth 3Y39.3%
Revenue growth 5Y21.8%
Sales Q2Q%9.14%

3.2 Future

  • The Earnings Per Share is expected to grow by 34.77% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, INVX will show a small growth in Revenue. The Revenue will grow by 4.22% on average per year.
EPS Next Y103.87%
EPS Next 2Y52.94%
EPS Next 3Y34.77%
EPS Next 5YN/A
Revenue Next Year3.75%
Revenue Next 2Y4.02%
Revenue Next 3Y4.22%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 32.94, the valuation of INVX can be described as expensive.
  • INVX's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.10. INVX is valued slightly more expensive when compared to this.
  • The Price/Forward Earnings ratio is 16.16, which indicates a correct valuation of INVX.
  • Based on the Price/Forward Earnings ratio, INVX is valued cheaper than 83.61% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, INVX is valued a bit cheaper.
Industry RankSector Rank
PE 32.94
Fwd PE 16.16
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • INVX's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, INVX is valued cheaply inside the industry as 83.61% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.86
EV/EBITDA 9.77
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • INVX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • INVX has a very decent profitability rating, which may justify a higher PE ratio.
  • INVX's earnings are expected to grow with 34.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)0.49
EPS Next 2Y52.94%
EPS Next 3Y34.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for INVX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INNOVEX INTERNATIONAL INC

NYSE:INVX (2/27/2026, 8:11:30 PM)

After market: 26.3 -0.05 (-0.19%)

26.35

-0.29 (-1.09%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-23
Earnings (Next)N/A
Inst Owners47.97%
Inst Owner Change3.05%
Ins Owners1.52%
Ins Owner Change-3.53%
Market Cap1.82B
Revenue(TTM)978.25M
Net Income(TTM)101.12M
Analysts77.78
Price Target25.5 (-3.23%)
Short Float %N/A
Short Ratio7.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-43.31%
Min EPS beat(2)-62.53%
Max EPS beat(2)-24.08%
EPS beat(4)1
Avg EPS beat(4)-15.03%
Min EPS beat(4)-62.53%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-142.72%
EPS beat(12)2
Avg EPS beat(12)-111.91%
EPS beat(16)3
Avg EPS beat(16)-84.71%
Revenue beat(2)1
Avg Revenue beat(2)2.01%
Min Revenue beat(2)-4.42%
Max Revenue beat(2)8.43%
Revenue beat(4)3
Avg Revenue beat(4)5.34%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)10.21%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.07%
Valuation
Industry RankSector Rank
PE 32.94
Fwd PE 16.16
P/S 1.9
P/FCF 12.86
P/OCF 10.38
P/B 1.75
P/tB 2.21
EV/EBITDA 9.77
EPS(TTM)0.8
EY3.04%
EPS(NY)1.63
Fwd EY6.19%
FCF(TTM)2.05
FCFY7.77%
OCF(TTM)2.54
OCFY9.64%
SpS13.86
BVpS15.07
TBVpS11.94
PEG (NY)0.32
PEG (5Y)0.49
Graham Number16.47
Profitability
Industry RankSector Rank
ROA 8.06%
ROE 9.73%
ROCE 10.56%
ROIC 8.61%
ROICexc 10.1%
ROICexgc 13.1%
OM 12.21%
PM (TTM) 10.58%
GM 32.35%
FCFM 14.78%
ROA(3y)6.11%
ROA(5y)1.09%
ROE(3y)7.53%
ROE(5y)1.62%
ROIC(3y)5.11%
ROIC(5y)N/A
ROICexc(3y)5.92%
ROICexc(5y)N/A
ROICexgc(3y)7.49%
ROICexgc(5y)N/A
ROCE(3y)6.27%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.34%
GM growth 5Y3.49%
F-Score8
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.19
Debt/EBITDA 0.12
Cap/Depr 59.02%
Cap/Sales 3.54%
Interest Coverage 80.3
Cash Conversion 100.59%
Profit Quality 139.63%
Current Ratio 4.78
Quick Ratio 2.93
Altman-Z 7.03
F-Score8
WACC8.61%
ROIC/WACC1
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)335.29%
EPS 3YN/A
EPS 5Y67.88%
EPS Q2Q%-42.86%
EPS Next Y103.87%
EPS Next 2Y52.94%
EPS Next 3Y34.77%
EPS Next 5YN/A
Revenue 1Y (TTM)26.86%
Revenue growth 3Y39.3%
Revenue growth 5Y21.8%
Sales Q2Q%9.14%
Revenue Next Year3.75%
Revenue Next 2Y4.02%
Revenue Next 3Y4.22%
Revenue Next 5YN/A
EBIT growth 1Y95.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year78.72%
EBIT Next 3Y28.79%
EBIT Next 5YN/A
FCF growth 1Y114.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.3%
OCF growth 3YN/A
OCF growth 5YN/A

INNOVEX INTERNATIONAL INC / INVX FAQ

Can you provide the ChartMill fundamental rating for INNOVEX INTERNATIONAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVX.


Can you provide the valuation status for INNOVEX INTERNATIONAL INC?

ChartMill assigns a valuation rating of 6 / 10 to INNOVEX INTERNATIONAL INC (INVX). This can be considered as Fairly Valued.


What is the profitability of INVX stock?

INNOVEX INTERNATIONAL INC (INVX) has a profitability rating of 6 / 10.


How financially healthy is INNOVEX INTERNATIONAL INC?

The financial health rating of INNOVEX INTERNATIONAL INC (INVX) is 9 / 10.


Can you provide the dividend sustainability for INVX stock?

The dividend rating of INNOVEX INTERNATIONAL INC (INVX) is 0 / 10 and the dividend payout ratio is 0%.